Macquarie Group’s Abiomed Inc ABMD Stock Holding History

Macquarie Group’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-504,989	Closed	-$124M	–	2230
2022 Q3	$124M	Buy	504,989 +16,568	+3%	+$4.47M	0.15%	167
2022 Q2	$121M	Sell	488,421 -5,855	-1%	-$1.58M	0.14%	188
2022 Q1	$164K	Buy	494,276 +2,779	+0.6%	+$855K	0.12%	177
2021 Q4	$177M	Buy	491,497 +5,162	+1%	+$1.74M	0.15%	176
2021 Q3	$158M	Buy	486,335 +3,155	+0.7%	+$1.07M	0.13%	190
2021 Q2	$151M	Buy	483,180 +472,508	+4,428%	+$145M	0.12%	198
2021 Q1	$3.4M	Sell	10,672 -38,571	-78%	-$12.3M	﹤0.01%	1015
2020 Q4	$16M	Sell	49,243 -11,630	-19%	-$3.22M	0.02%	589
2020 Q3	$16.9M	Sell	60,873 -8,751	-13%	-$2.52M	0.03%	523
2020 Q2	$16.8M	Buy	69,624 +17,266	+33%	+$3.47M	0.03%	511
2020 Q1	$7.6M	Sell	52,358 -10,851	-17%	-$1.8M	0.02%	622
2019 Q4	$10.8M	Buy	63,209 +23,164	+58%	+$4.29M	0.02%	633
2019 Q3	$7.12M	Sell	40,045 -92,057	-70%	-$19.9M	0.01%	678
2019 Q2	$34.4M	Sell	132,102 -22,595	-15%	-$5.99M	0.06%	340
2019 Q1	$44.2M	Buy	154,697 +112,122	+263%	+$37.3M	0.08%	279
2018 Q4	$13.8M	Sell	42,575 -14,522	-25%	-$5.04M	0.03%	524
2018 Q3	$25.7M	Sell	57,097 -4,476	-7%	-$1.76M	0.04%	417
2018 Q2	$25.2M	Sell	61,573 -72,273	-54%	-$26.2M	0.04%	431
2018 Q1	$38.9M	Sell	133,846 -110,021	-45%	-$27.9M	0.07%	292
2017 Q4	$45.7M	Sell	243,867 -23,083	-9%	-$4.31M	0.08%	240
2017 Q3	$45M	Sell	266,950 -66,903	-20%	-$10.1M	0.08%	229
2017 Q2	$47.8M	Sell	333,853 -139,509	-29%	-$18.7M	0.09%	207
2017 Q1	$59.3M	Buy	473,362 +60,682	+15%	+$7.03M	0.11%	153
2016 Q4	$46.5M	Sell	412,680 -87,718	-18%	-$10.2M	0.09%	189
2016 Q3	$64.3M	Sell	500,398 -1,119,014	-69%	-$134M	0.12%	134
2016 Q2	$177M	Buy	1,619,412 +434,226	+37%	+$43.2M	0.17%	104
2016 Q1	$112M	Sell	1,185,186 -41,422	-3%	-$3.5M	0.23%	86
2015 Q4	$111M	Buy	1,226,608 +127,037	+12%	+$10.8M	0.23%	86
2015 Q3	$102M	Sell	1,099,571 -102,999	-9%	-$9.08M	0.22%	91
2015 Q2	$79M	Sell	1,202,570 -21,484	-2%	-$1.43M	0.16%	117
2015 Q1	$87.6M	Sell	1,224,054 -840,826	-41%	-$45.6M	0.17%	114
2014 Q4	$78.6M	Sell	2,064,880 -1,140,485	-36%	-$36M	0.16%	121
2014 Q3	$79.6M	Sell	3,205,365 -291,488	-8%	-$7.38M	0.17%	115
2014 Q2	$87.9M	Sell	3,496,853 -1,878,178	-35%	-$43.7M	0.2%	116
2014 Q1	$140M	Buy	5,375,031 +167,358	+3%	+$4.63M	0.24%	87
2013 Q4	$139M	Buy	5,207,673 +94,951	+2%	+$2.35M	0.25%	88
2013 Q3	$97.5M	Buy	5,112,722 +53,282	+1%	+$1.22M	0.19%	100
2013 Q2	$109M	Buy	+5,059,440	New	+$102M	0.24%	91

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Macquarie Group's ABMD Position: Q4 2022 in Review

Macquarie Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 504,989 shares — an estimated $124M sold.

Macquarie Group first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $177M in Q2 2016. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Macquarie Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Macquarie Group sold 504,989 Abiomed Inc shares in Q4 2022, an estimated $124M.
Macquarie Group first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
Macquarie Group's Abiomed Inc position peaked at $177M in Q2 2016.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.